The Clinical Features of Sarcoidosis: A Comprehensive Review

被引:0
作者
Marc A. Judson
机构
[1] Albany Medical Center,Division of Pulmonary and Critical Care Medicine
来源
Clinical Reviews in Allergy & Immunology | 2015年 / 49卷
关键词
Sarcoidosis; Organ involvement; Symptoms; Manifestations;
D O I
暂无
中图分类号
学科分类号
摘要
Sarcoidosis has innumerable clinical manifestations, as the disease may affect every body organ. Furthermore, the severity of sarcoidosis involvement may range from an asymptomatic state to a life-threatening condition. This manuscript reviews a wide variety of common and less common clinical characteristics of sarcoidosis. These manifestations are presented organ by organ, although additional sections describe systemic and multiorgan presentations of sarcoidosis. The lung is the organ most commonly involved with sarcoidosis with at least 90 % of sarcoidosis patients demonstrating lung involvement in most series. The skin, eye, liver, and peripheral lymph node are the next most commonly clinically involved organs in most series, with the frequency of involvement ranging from 10 to 30 %. The actual frequency of sarcoidosis organ involvement is probably much higher as it is frequently asymptomatic and may avoid detection. This is particularly common with lung, liver, cardiac, and bone involvement. Cardiac sarcoidosis is present in 25 % of all sarcoidosis but only causes clinical problems in 5 % of them. Nevertheless, unlike sarcoidosis involvement of most other organs, it may be suddenly fatal. Therefore, it is important to screen for cardiac sarcoidosis in all sarcoidosis patients. All sarcoidosis patients should also be screened for eye involvement as asymptomatic patients may have eye involvement that may cause permanent vision impairment. Pulmonary fibrosis from sarcoidosis is usually slowly progressive but may be life-threatening because of the development of respiratory failure, pulmonary hypertension, or hemoptysis related to a mycetoma or bronchiectasis. Some manifestations of sarcoidosis are not organ-specific and probably are the result of a release of mediators from the sarcoid granuloma. Two such manifestations include small fiber neuropathy and fatigue syndromes, and they are observed in a large percentage of patients.
引用
收藏
页码:63 / 78
页数:15
相关论文
共 619 条
[1]  
Prasse A(2008)Phenotyping sarcoidosis from a pulmonary perspective Am J Respir Crit Care Med 177 330-336
[2]  
Katic C(2000)Sarcoidosis: a long-term follow up study Sarcoidosis Vasc Diffuse Lung Dis 17 167-173
[3]  
Germann M(2011)Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force Sarcoidosis Vasc Diffuse Lung Dis 28 56-64
[4]  
Chappell AG(2012)Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Eur Respir J 39 1520-1533
[5]  
Cheung WY(2011)Sarcoidosis-related mortality in the United States from 1988 to 2007 Am J Respir Crit Care Med 183 1524-1530
[6]  
Hutchings HA(1981)Mortality in sarcoidosis. A changing pattern of the causes of death Eur J Respir Dis 62 231-238
[7]  
Baughman RP(2001)Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation Chest 120 873-880
[8]  
Nagai S(2009)Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes Am J Cardiol 104 571-577
[9]  
Balter M(1994)Racial difference in cardiac sarcoidosis incidence observed at autopsy Sarcoidosis 11 26-31
[10]  
Shlobin OA(2006)Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics Clin Chest Med 27 453-462